Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 20; no. 5; pp. 905 - 907
Main Authors:	Kelaidi, C, Ades, L, Chevret, S, Sanz, M, Guerci, A, Thomas, X, de Botton, S, Raffoux, E, Rayon, C, Fegueux, N, Bordessoule, D, Rigal-Huguet, F, Link, H, Stoppa, A, Vekhoff, A, Meyer-Monard, S, Castaigne, S, Dombret, H, Degos, L, Fenaux, P
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01-05-2006 Springer Nature
Subjects:	Adult Aged Anthracycline Anthracyclines Anthracyclines - administration & dosage Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols - therapeutic use Arsenicals Arsenicals - therapeutic use Chemotherapy Combined Modality Therapy Europe Female Humans Immunology Leukemia, Promyelocytic, Acute Leukemia, Promyelocytic, Acute - diagnosis Leukemia, Promyelocytic, Acute - drug therapy Life Sciences Male Middle Aged Oxides Oxides - therapeutic use Prognosis Recurrence Retinoic acid Risk Factors Treatment Outcome Tretinoin Tretinoin - administration & dosage Europe
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Feature-1 ObjectType-Correspondence-3
ISSN:	0887-6924 1476-5551
DOI:	10.1038/sj.leu.2404158